Study summary · 2025 · Evidence review

RPM and hospital use across chronic diseases

RPM may modestly reduce the proportion of patients hospitalized; broader utilization effects remain uncertain.

Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence

Original publication

Effects of Remote Patient Monitoring on Health Care Utilization in Patients With Noncommunicable Diseases: Systematic Review and Meta-Analysis

Geir Smedslund; Nina Østerås; Christine Hillestad Hestevik

Diakonhjemmet Hospital and Norwegian Institute of Public Health, Oslo, Norway

JMIR mHealth and uHealth · Online: · Issue: 2025

Journal version of record; earlier JMIR preprint not counted separately. · Full text consulted.

What was studied

Design
Evidence review
Population
People with noncommunicable diseases
Sample
40 randomized trials
Intervention
Digital health-data transmission to care teams
Comparator
Usual care
Follow-up
Varied by trial
Review search cutoff
2024-06
Setting
Multiple countries; predominantly high-income settings

Methods

Random-effects synthesis of randomized trials, with risk-of-bias and GRADE assessments.

Findings

Hospitalization risk ratio was 0.86 (95% CI 0.77–0.95; low certainty). Length of stay differed by −0.84 days (95% CI −1.61 to −0.06; low certainty). Emergency-visit effects were unclear.

Limitations

Only 8 of 40 trials had low risk of bias; 16 had some concerns and 16 high risk. Interventions included symptom reporting as well as measurements. Admission counts and some outpatient endpoints were inconclusive; certainty ranged from moderate to very low.

What this means for care delivery

Use condition-specific evidence alongside this broad review; it does not establish that every RPM service reduces admissions or spending.